Cardioprotective and cardiotoxic effects of quercetin and two of its in vivo metabolites on differentiated H9c2 cardiomyocytes

Basic and Clinical Pharmacology and Toxicology

Volumn 116, Issue 2, 2015, Pages 96-109

  Daubney, James ^a   Bonner, Philip L ^a   Hargreaves, Alan J ^a   Dickenson, John M ^a  

^a NOTTINGHAM TRENT UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

3' O METHYL QUERCETIN; CASPASE 3; DRUG METABOLITE; JANUS KINASE; LACTATE DEHYDROGENASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN KINASE B; QUERCETIN; QUERCETIN 3 GLUCURONIDE; REACTIVE OXYGEN METABOLITE; RETINOIC ACID; UNCLASSIFIED DRUG; 3-METHYLQUERCETIN; CARDIOTONIC AGENT; HYDROGEN PEROXIDE; QUERCETIN 3-O-GLUCURONIDE;

ANIMAL CELL; ARTICLE; CARDIOTOXICITY; CELL DAMAGE; CELL DIFFERENTIATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME RELEASE; HEART MUSCLE CELL; HEART PROTECTION; IMMUNOCYTOCHEMISTRY; IN VIVO STUDY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; WESTERN BLOTTING; ANALOGS AND DERIVATIVES; ANIMAL; CELL DEATH; CELL LINE; DRUG EFFECTS; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION;

RATTUS;

ANIMALS; CARDIOTONIC AGENTS; CELL DEATH; CELL DIFFERENTIATION; CELL LINE; HYDROGEN PEROXIDE; MYOCYTES, CARDIAC; OXIDATIVE STRESS; QUERCETIN; RATS; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION;

EID: 84921421114     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/bcpt.12319     Document Type: Article

References (43)

1. Middleton E Jr, Kandaswami C, Theoharides TC. The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease and cancer. Pharmacol Rev 2000;52:673-751.
2. Beecher GR. Overview of dietary flavonoids: nomenclature, occurrence and intake. J Nutr 2003;133:3248S-54S.
3. Del Rio D, Rodriguez-Mateos A, Spencer JP, Tognolini M, Borges G, Crozier A. Dietary (poly)phenolics in human health: structures, bioavailability, and evidence of protective effects against chronic diseases. Antioxid Redox Signal 2013;18:1818-92.
4. Russo M, Spagnuolo C, Tedesco I, Bilotto S, Russo GL. The flavonoid quercetin in disease prevention and therapy: facts and fancies. Biochem Pharmacol 2012;83:6-15.
5. Roskosko R Jr. ERK1/2 MAP kinases: structure, function and regulation. Pharmacol Res 2012;66:105-43.
6. Gutiérrez-Venegas G, Bando-Campos CG. The flavonoids luteolin and quercetagetin inhibit lipoteichoic acid actions on H9c2 cardiomyocytes. Int Immunopharmacol 2010;10:1003-9.
7. Angeloni C, Hrelia S. Quercetin reduces inflammatory responses in LPS-stimulated cardiomyoblasts. Oxid Med Cell Longev 2012;2012:583901.
8. Weng CJ, Chen MJ, Yeh CT, Yen GC. Hepatoprotection of quercetin against oxidative stress by induction of metallothionein expression through activating MAPK and PI3K pathways and enhancing Nrf2 DNA-binding activity. New Biotechnol 2011;28:767-77.
9. Walker EH, Pacold ME, Perisic O, Stephens L, Hawkins PT, Wymann MP etal. Structural determinants of phosphoinositide 3-kinase inhibition by wortmannin, LY294002, quercetin, myricetin, and staurosporine. Mol Cell 2000;6:909-19.
10. Armstrong SC. Protein kinase activation and myocardial ischaemia/reperfusion injury. Cardiovasc Res 2004;61:427-36.
11. Hausenloy DJ, Yellon DM. Preconditioning and postconditioning: united at reperfusion. Pharmacol Ther 2007;114:208-21.
12. Shao Z-H, Wojcik KR, Dossumbekova A, Hsu C, Mehendale SR, Li C-Q etal. Grape seed proanthocyanidins protect cardiomyocytes from ischemia and reperfusion injury via Akt-NOS signaling. J Cell Biochem 2009;107:697-705.
13. Angeloni C, Spencer JPE, Leoncini E, Biagi PL, Hrelia S. Role of quercetin and its in vivo metabolites in protecting H9c2 cells against oxidative stress. Biochimie 2007;89:73-82.
14. 2-induced activation of the intrinsic apoptotic pathway in H9c2 cardiomyocytes through scavenging reactive oxygen species and ERK inactivation. J Cell Biochem 2012;113:473-85.
15. Kimes BW, Brandt BL. Properties of a clonal muscle cell line from rat heart. Exp Cell Res 1976;98:367-81.
16. Kim DS, Kwon DY, Kim MS, Lee YC, Park SJ, Yoo WH etal. The involvement of endoplasmic reticulum stress in flavonoid-induced protection of cardiac cell death caused by ischaemia/reperfusion. J Pharm Pharmacol 2010;62:197-204.
17. Mojzisová G, Sarisský M, Mirossay L, Martinka P, Mojzis J. Effects of flavonoids on daunorubicin-induced toxicity in H9c2 cardiomyoblasts. Phytother Res 2009;23:136-9.
18. Hescheler J, Meyer R, Plant S, Krautwurst D, Rosenthal W, Schultz G. Morphological, biochemical and electrophysiological characterization of a clonal cell (H9c2) line from rat heart. Circ Res 1991;69:1476-86.
19. Ménard C, Pupier S, Mornet D, Kitzmann M, Nargeot J, Lory P. Modulation of L-type channel expression during retinoic acid-induced differentiation of H9c2 cardiac cells. J Biol Chem 1999;274:29063-70.
20. Comelli M, Domenis R, Bisetto E, Contin M, Marchini M, Ortolani F etal. Cardiac differentiation promotes mitochondria development and ameliorates oxidative capacity in H9c2 cardiomyoblasts. Mitochondrion 2011;11:315-26.
21. Spencer JPE, Kuhnle GGC, Williams RJ, Rice-Evans C. Intracellular metabolism and bioactivity of quercetin and its in vivo metabolites. Biochem J 2003;372:173-81.
22. Metodiewa D, Jaiswak AK, Cenas N, Dickancaité E, Sequra-Aguilar J. Quercetin may act as a cytotoxic pro-oxidant after its metabolic activation to semiquinone and quinoidal product. Free Radic Biol Med 1999;26:107-16.
23. Kamata H, Hirata H. Redox regulation of cellular signalling. Cell Signal 1999;11:1-14.
24. Clerk A, Fuller SJ, Michael A, Sugden PH. Stimulation of "stress-regulated" mitogen-activated protein kinases (stress-activated protein kinases/c-Jun N-terminal kinases and p38-mitogen-activated protein kinases) in perfused hearts by oxidative and other stresses. J Biol Chem 1998;273:7228-34.
25. Pham FH, Sugden PH, Clerk A. Regulation of protein kinase B and 4E-BP1 by oxidative stress in cardiac myocytes. Circ Res 2000;86:1252-8.
26. Takeishi Y, Abe J, Lee J-D, Kawakatsu H, Walsh RA, Berk BC. Differential regulation of p90 ribosomal S6 kinase and Big-mitogen-activated protein kinase 1 by ischemia/reperfusion and oxidative stress in perfused guinea-pig hearts. Circ Res 1999;85:1164-72.
27. Fotakis G, Timbrell JA. In vitro cytotoxic assays: comparison of LDH, neutral red, MTT and protein assay in hepatoma cells following exposure to cadmium chloride. Toxicol Lett 2006;160:171-7.
28. Kim YH, Lee YJ. TRAIL apoptosis is enhanced by quercetin through Akt dephosphorylation. J Cell Biochem 2007;100:998-1009.
29. Russo M, Spagnuolo C, Volpe S, Mupo A, Tedesco I, Russo GL. Quercetin induced apoptosis in association with death receptors and fludarabine in cells isolated from chronic lymphocytic patients. Br J Cancer 2010;103:642-8.
30. Spencer JPE, Rice-Evans C, Williams RJ. Modulation of pro-survival Akt/protein kinase B and ERK1/2 signaling cascades by quercetin and its in vivo metabolites underlie their action on neuronal viability. J Biol Chem 2003;278:34783-93.
31. Repetto G, del Peso A, Zurita JL. Neutral red uptake assay for the estimation of cell viability/cytotoxicity. Nat Protoc 2008;3:1125-31.
32. Hers I, Vincent EE, Tavaré JM. Akt signalling in health and disease. Cell Signal 2011;23:1515-27.
33. Lu Z, Xu S. ERK1/2 MAP kinases in cell survival and apoptosis. IUBMB Life 2006;58:621-31.
34. Lee KW, Kang NJ, Heo YS, Rogozin EA, Pugliese A, Hwang MK etal. Raf and MEK protein kinases are direct molecular targets for the chemopreventive effect of quercetin, a major flavonol in red wine. Cancer Res 2008;68:946-55.
35. 2-induced apoptosis via anti-oxidant activity and heme oxygenase 1 gene expression in macrophages. Biochem Pharmacol 2005;69:1839-51.
36. Youl E, Bardy G, Magous R, Cros G, Sejalon F, Virsolvy A etal. Quercetin potentiates insulin secretion and protects INS-1 pancreatic β-cells against oxidative stress damage via the ERK1/2 pathway. Br J Pharmacol 2010;161:799-814.
37. Gulati N, Laudet B, Zohrabian VM, Murali R, Jhanwar-Uniyal M. The antiproliferative effect of quercetin in cancer cells is mediated via inhibition of the PI3K-Akt/PKB pathway. Anticancer Res 2006;26:1177-82.
38. Chang YC, Lee TS, Chiang AN. Quercetin enhances ABCA1 expression and cholesterol efflux through a p38-dependent pathway in macrophages. J Lipid Res 2012;53:1840-50.
39. Spencer JPE. The interactions of flavonoids within neuronal signalling pathways. Genes Nutr 2007;2:257-73.
40. Davies SP, Reddy H, Caivano M, Cohen P. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J 2000;351:95-105.
41. Boly R, Gras T, Lamkami T, Guissou P, Sertyn D, Kiss R etal. Quercetin inhibits a large panel of kinases implicated in cancer biology. Int J Oncol 2011;38:833-42.
42. Williamson G, Barron D, Shimoi K, Terao J. In vitro biological properties of flavonoid conjugates found in vivo. Free Radic Res 2005;39:457-69.
43. Kawai Y, Nishikawa T, Shiba Y, Saito S, Murota K, Shibata N etal. Macrophage as a target of quercetin glucuronides in human atherosclerotic arteries: implication in the anti-atherosclerotic mechanism of dietary flavonoids. J Biol Chem 2008;283:9424-34.